Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04478890
Other study ID # ANES-2020-28725
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2021
Est. completion date September 1, 2024

Study information

Verified date April 2024
Source University of Minnesota
Contact Tjorvi E Perry, MD, MMSc
Phone 6124027900
Email perry655@umn.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study will include the placement of a pressure volume (PV) loop catheter in the right atrium of patients undergoing left ventricular assist device (LVAD) placement and measure relevant PV loop data. Transesophageal echocardiography (TEE) and pulmonary artery (PA) catheter parameters as comparators to the PV loop will be recorded.


Description:

This will be a prospective observational study design to characterize right ventricular function in 5 consecutive patients undergoing LVAD implantation at the University of Minnesota Medical Center (UMMC). Pre-, intra- and postoperative care delivery to all enrolled and consented patients will meet the standards of care otherwise delivered to patients undergoing LVAD implantation at UMMC; care delivery will be at the discretion of the clinical care team and will not be altered based on the output of the right ventricular high-fidelity conductance catheters.


Recruitment information / eligibility

Status Recruiting
Enrollment 5
Est. completion date September 1, 2024
Est. primary completion date September 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing left ventricular assist device (LVAD) placement at the University of Minnesota Medical Center Exclusion Criteria: - Patients with a history of internal jugular vein thrombosis or known reasons for not being able to thread a central venous catheter through either internal jugular vein - Patients with a history of known esophageal strictures, esophageal or stomach cancer, esophageal varices, or any patient in whom a TEE is contraindicated - Patients with permanent pacemakers whose right ventricle is being paced and not in normal sinus rhythm - Patients unable to consent to participating in the study - Patients who are pregnant will be excluded, as part of standard care, all female patients are screened for pregnancy prior to surgery.

Study Design


Intervention

Diagnostic Test:
Hemodynamic assessment
Hemodynamic assessment of the right ventricle using pressure-volume loop catheter and pulmonary artery catheter

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stroke volume Stroke volume will be reported in units of millilitres per square metre Approximately 4-6 hours
Primary Heart rate Heart rate will be reported in units of beats per minute Approximately 4-6 hours
Primary Ejection fraction Ejection fraction will be reported as a percent Approximately 4-6 hours
Primary Cardiac output Cardiac output will be reported in units of milliliters per minute Approximately 4-6 hours
Primary End-systolic pressure End-systolic pressure will be reported in units of mmHG Approximately 4-6 hours
Primary End-systolic volume End-systolic volume will be reported in units of milliliters Approximately 4-6 hours
Primary End-diastolic pressure End-diastolic pressure will be reported in units of mmHG Approximately 4-6 hours
Primary End-diastolic volume End-diastolic volume will be reported in units of milliliters Approximately 4-6 hours
Primary Right ventricular dP/dt Right ventricular dP/dt will be reported in units of mmHg per second Approximately 4-6 hours
Primary Stroke work Stroke work will be reported in units of gram meters (g*m) Approximately 4-6 hours
See also
  Status Clinical Trial Phase
Completed NCT03183414 - Right Ventricular Dysfunction in Cardiac Surgery Patients
Recruiting NCT04764032 - Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Not yet recruiting NCT05188222 - Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery Phase 4
Completed NCT05948332 - Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
Not yet recruiting NCT06002321 - Right Ventricular Dysfunction in Chronic Heart Failure
Recruiting NCT03309852 - Emergency Department Assessment of Right Ventricular Function and Size in the Post Cardiac Arrest Patient
Recruiting NCT05583461 - Ventilator-induced Right Ventricular Injury During EIT-based PEEP Titration in Patients With ARDS N/A
Completed NCT03438825 - PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients
Active, not recruiting NCT01230294 - New Echocardiographic Methods for Right Ventricular Function. N/A
Completed NCT00557934 - Right Ventricular Contractility Reserve Following Repair of Tetralogy of Fallot N/A
Completed NCT04694378 - Relationship Between Strain and Stroke Volume in Cardiac Surgery
Not yet recruiting NCT04167241 - Right Ventricle Function After Major Right Lung Resection
Recruiting NCT03013075 - General Plus Spinal Anesthesia and General Anesthesia Alone on Right Ventricular Function Phase 4
Completed NCT06197256 - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Completed NCT03301571 - Right Ventricular Echocardiography in caRdiac SurgEry N/A
Recruiting NCT05860504 - Acute Cardiac Dysfunction in Critical Illnes
Completed NCT01093001 - Tricuspid Regurgitation Study Phase 4
Recruiting NCT05758194 - Mitigating Post-Op RV Dysfunction After LVAD Implantation N/A
Not yet recruiting NCT05768230 - Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV Phase 2/Phase 3
Not yet recruiting NCT05620992 - Evaluation of Right Ventricular Function Post Mitral Valve Operations